We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for cannabidiol (Emerge Health Pty Ltd)
Active ingredients
cannabidiol
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
Indicated for use as adjunctive therapy of seizures associated with Dravet syndrome (DS) for patients 2 years of age and older
Therapeutic area
Neurology